Common painkillers may increase heart failure risk

Bs_logoImage
Press Trust of India London
Last Updated : Sep 29 2016 | 3:57 PM IST
Common painkillers such as ibuprofen and diclofenac may lead to a significantly increased risk of heart failure, particularly in older adults, a new study has warned.
The study analysed data for 10 million users from the UK, the Netherlands, Italy and Germany aged 77 on average, and compared them with people who did not take the drugs.
The researchers, from University of Milano-Bicocca in Italy, found taking non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, naproxen and diclofenac, increased the risk of being taken to hospital with heart failure by 19 per cent.
Since most people in the study were older - and those on NSAIDs were, in general, in poorer health - experts said that the findings had little relevance for most under-65s but may be a concern for elderly patients.
According to the British Heart Foundation (BHF), patients should be on the lowest dose possible of NSAIDs for the shortest possible time.
"This large observational study reinforces previous research showing that some NSAIDs, a group of drugs commonly taken by patients with joint problems, increase the risk of developing heart failure," said Peter Weissberg, medical director at the BHF.
The focus needed to be on older patients with conditions or diseases that might put them at increased risk of heart failure anyway, Helen Williams, consultant pharmacist for cardiovascular disease at the Royal Pharmaceutical Society, told the 'BBC'.
"Hypertension, diabetes, maybe kidney problems - it's in those patients when we add these drugs on top that there might be a small increase in their risk," Williams said.
The study was published in the BMJ journal.

Disclaimer: No Business Standard Journalist was involved in creation of this content

You’ve reached your limit of 10 free articles this month.
Subscribe now for unlimited access.

Already subscribed? Log in

Subscribe to read the full story →
Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories

  • Over 30 subscriber-only stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 29 2016 | 3:57 PM IST